[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334118-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334118-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","causal-effect-between-breast-cancer-and-ovarian-cancer-a-two-sample-mendelian-randomization-study","Causal effect between breast cancer and ovarian cancer - a two-sample mendelian randomization study","","Improved breast cancer outcomes increase the need to understand secondary primary cancers, particularly ovarian cancer, in survivor prognosis. This study investigated the genetic association and potential causal relationship between primary breast cancer and ovarian cancer using a two-sample Mendelian randomization framework. Aggregate GWAS data were used, and Genetic Risk Scores supported secondary analyses to test robustness. Results indicated genetic correlations across specific breast cancer subtypes and ovarian cancer histological categories.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/causal-effect-between-breast-cancer-and-ovarian-cancer-a-two-sample-mendelian-randomization-study/334118/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/causal-effect-between-breast-cancer-and-ovarian-cancer-a-two-sample-mendelian-randomization-study/334118.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective?","Question",{"text":63,"@type":64},"To investigate the potential genetic association between primary breast cancer and ovarian cancer, supporting preventive strategy development for ovarian cancer after breast cancer surgery.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers evaluate the relationship between breast cancer and ovarian cancer?",{"text":68,"@type":64},"They applied a two-sample Mendelian randomization approach using aggregate-level GWAS data and used Genetic Risk Scores as a secondary analysis to assess robustness.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the primary MR results suggest?",{"text":72,"@type":64},"The IVW method showed genetic correlations between overall breast cancer and specific breast cancer subtypes with particular ovarian tumor categories, while ER- breast cancer correlated with other ovarian cancer types.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334118,1790176390,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Qian et al. BMC Cancer (2024) 24:1433 [https://doi.org/10.1186/s12885-024-13033-8](https://doi.org/10.1186/s12885-024-13033-8)  \nBMC Cancer  \n RESEARCH Open Access  \nCausal effect between breast cancer   and ovarian cancer: a two-sample mendelian randomization study  \nCheng Qian1 , Yan Xing1 and Wenjun Cheng1*  \nAbstract  \nObjectives Improved breast cancer (BC) outcomes highlight the importance of secondary primary cancers (SPCs) on survivor prognosis. The objective of this study was to investigate the potential genetic association between primary BC and ovarian cancer (OC), laying the groundwork for the development of preventive strategies for SPC-OC following BC surgery.  \nMethods This study aimed to assess the connection between BC and OC using a two sample Mendelian randomization (MR) approach, exclusively employing aggregate level data from publicly available genome wide association studies (GWASs) . Finally, the Genetic Risk Scores (GRS) method was used for secondary analysis to verify the results robustness further.  \nResults The IVW method revealed a genetic correlation between Overall BC and ER + BC with Serous borderline tumors, while ER-BC exhibited genetic correlation with Mucinous borderline tumors and high-grade serous ovarian cancer. The findings from the GRS method aligned with those of the primary analysis, reinforcing the study’s robustness.  \nConclusion Our MR Study identifies an association between BC and OC, highlighting the importance of increased vigilance in clinical practice for individuals with a history of BC. Timely intervention and treatment measures should betaken when necessary.  \nKeywords Mendelian randomization, Breast cancer, Ovarian cancer, Genetic association, Causal relationship  \nIntroduction  \nIn the United States, according to the 2022 statistics on breast cancer among women by the American Cancer Society, the incidence of breast cancer (BC) has steadily increased over most of the past four decades. In 2022, an estimated 287,850 new cases of invasive BC and 51,400 cases of ductal carcinoma in situ are expected  \n*Correspondence:  \nWenjun Cheng [chengwenjun@jsph.org.cn](chengwenjun@jsph.org.cn)  \n1 Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, Jiangsu 210029, People’s Republic of China  \nto be diagnosed among American women, and an estimated 43,250 deaths [1]. According to data compiled by the National Cancer Institute, the 5-year survival rate for breast cancer patients in the United States improved significantly, with an overall rate of 91%[2]. However, as breast cancer patients survive longer, the incidence of second primary cancers (SPCs) has increased [3]. According to data provided by the American Cancer Society, a considerable number of individuals in the United States have successfully overcome BC, indicating the importance of screening for SPCs. Regular screening for ovarian cancer (OC), which is associated with women’s health, is crucial to ensure the ongoing health of this diverse patient population within these SPCs.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to ","cbCaic8VWrpMbe1D","https://ap.wps.com/l/cbCaic8VWrpMbe1D","pdf",2321626,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To investigate the potential genetic association between primary breast cancer and ovarian cancer, supporting preventive strategy development for ovarian cancer after breast cancer surgery.\"},{\"question\":\"How did the researchers evaluate the relationship between breast cancer and ovarian cancer?\",\"answer\":\"They applied a two-sample Mendelian randomization approach using aggregate-level GWAS data and used Genetic Risk Scores as a secondary analysis to assess robustness.\"},{\"question\":\"What did the primary MR results suggest?\",\"answer\":\"The IVW method showed genetic correlations between overall breast cancer and specific breast cancer subtypes with particular ovarian tumor categories, while ER- breast cancer correlated with other ovarian cancer types.\"}]","Causal effect between breast cancer and ovarian cancer - a two-sample mendelian randomization study | PDF",1790005374,25]